Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124980 |
TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Resolved | 2020-10-01 | 2020-11-07 | 125464 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2020-10-01 | 2020-11-07 | 125473 |
TEVA-INDOMETHACIN | 50MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126924 |
TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2020-10-22 | 2020-11-07 | 126930 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2020-08-06 | 2020-11-07 | 121865 |
TEVA-SULINDAC | 150MG | TABLET | Resolved | 2020-09-24 | 2020-11-07 | 124998 |
TEVA-TRIACOMB | 1MG 100000UNIT 2.5MG 0.25MG | CREAM | Resolved | 2020-10-01 | 2020-11-07 | 125488 |
TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-06-18 | 2020-11-12 | 118265 |
TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-08-27 | 2020-11-12 | 123081 |
TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-09-24 | 2020-11-12 | 125004 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-09-24 | 2020-11-12 | 125007 |
TEVA-SUMATRIPTAN DF | 50MG | TABLET | Resolved | 2020-10-01 | 2020-11-12 | 125476 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-10-22 | 2020-11-12 | 126918 |
TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128007 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128019 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-09-17 | 2020-11-12 | 124477 |
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2020-10-30 | 2020-11-12 | 127610 |
TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2020-11-06 | 2020-11-12 | 128037 |
TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-09-17 | 2020-11-19 | 124480 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |